Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign

Abstract

Objectives The outbreak of 2019 coronavirus disease (COVID-19) pandemic in Wuhan, China, has subsided after a hard hit by the disease and subsequent city lockdown. Information on the number of people involved in Wuhan is still inadequate. This study aimed to describe the screening results of 61,437 community members in Wuchang District, Wuhan. Methods In mid-May 2020, Wuhan launched a population-scale city-wide SARS-CoV-2 testing campaign, which aimed to perform nucleic acid and viral antibody testing for citizens in Wuhan. Here we show the screening results of cluster sampled 61,437 residents in Wuchang District, Wuhan, China. Results A total of 1470 (2.39%, 95% CI: 2.27-2.52) individuals were detected positive for at least one antiviral antibody. Among the positive individuals, 324 (0.53%, 95% CI: 0.47-0.59) and 1200 (1.95%, 95% CI: 1.85-2.07) were positive for immunoglobulin IgM and IgG, respectively, and 54 (0.08%, 95% CI: 0.07-0.12) were positive for both antibodies. The positive rate of female carriers of antibodies were higher than those of male counterparts (male-to-female ratio of 0.75), especially in elderly citizens (ratio of 0.18 in 90+ age subgroup), indicating a sexual discrepancy in seroprevalence. In addition, viral nucleic acid detection using real-time PCR had showed 8 (0.013%, 95% CI: 0.006-0.026) asymptomatic virus carriers. Conclusions The seroprevalence of SARS-CoV-2 in Wuhan was low. Most of Wuhan residents are still susceptible to this virus. Precautions, such as wearing mask, frequent hand hygiene, and proper social distance, are necessary before an effective vaccine or antiviral treatments are available.

Occurrence of COVID-19 symptoms during SARS-CoV-2 infection defines waning of humoral immunity

“…A total of 1,219 plasma specimens obtained from 987 individuals showed at least one type of SARS-CoV-2-specific antibodies, corresponding to an overall sero-prevalence of 3.93% among the participants. This prevalence is highly consistent with two previous studies conducted among Wuhan residents which described sero-positivity rates of 2.39% and 3.9% (17,18). After applying reliability criteria such as uncertainty of medical information, repetitive testing during a one-month period, and IgM positivity only (see the M&M section for details), 864 subjects represented by 990 plasma samples were included in this study (Fig.…”

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel

“…In agreement with our results, Rosenberg et al [ 13 ] and Iversen et al [ 14 ] also reported higher seroprevalence in males. In contrast, other studies reported a higher seroprevalence in females vs males, [ 15 , 16 ] so the issue remains controversial.…”

Facial paralysis as the only symptom of COVID-19: A prospective study

“…Asymptomatic individuals from the randomly selected sample participated in a Spanish study investigated COVID-19 IgG and/or IgM and the prevalence was found as 5.47% [ 40 ]. The seroprevalence of SARS-CoV-2 IgG and/or IgM antibody in asymptomatic individuals was found to be 2.39% in Wuhan [ 41 ]. The highest prevalence of SARS-CoV-2 antibodies in the literature was found among asymptomatic people in Sergipe, Brazil.…”